
Ergomed Investor Relations Material
Latest events

H2 2022
Ergomed
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ergomed plc
Access all reports
Ergomed plc, operates as a clinical research service provider for pharmaceutical and biotechnology companies internationally. The company offers services at all stages of the clinical development process, from study feasibility to final data analysis and reporting. It also provides various resources and services that support the conduct of clinical trials, including patient recruitment, monitoring support, data management, training services, analytical laboratory studies in toxicology, pharmacokinetics/pharmacodynamics (PK/PD), clinical trial material manufacturing (CTM), pharmacovigilance and medical information services. In addition, the company provides certain services to the non-interventional post-marketing phase of drug development; and in support of over-the-counter (OTC) products.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ERGO
Country
🇬🇧 United Kingdom